Skip to main content
An official website of the United States government

MVAC regimen

View Patient Information
A regimen consisting of methotrexate, vinblastine, doxorubicin, and cisplatin used for the treatment of advanced-stage urothelial carcinoma, including bladder cancer.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:M-VAC regimen
methotrexate-vinblastine sulfate-doxorubicin hydrochloride-cisplatin regimen
methotrexate-vinblastine-adriamycin-cisplatin regimen
methotrexate-vinblastine-doxorubicin-cisplatin regimen
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search